| Tretinoin | Approved Investigational Nutraceutical | RARB | 5915 |
upregulated | Tretinoin results in increased expression of RARB mRNA alternative form | 3p24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RARG | 5916 |
upregulated | Tretinoin results in increased expression of RARG mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | RARRES1 | 5918 |
upregulated | Tretinoin results in increased expression of RARRES1 mRNA | 3q25.32 | |
| Tretinoin | Approved Investigational Nutraceutical | RARRES2 | 5919 |
downregulated | Tretinoin results in decreased expression of RARRES2 mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RARRES3 | 5920 |
upregulated | Tretinoin results in increased expression of RARRES3 mRNA | 11q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | RARS | 5917 |
downregulated | Tretinoin results in decreased expression of RARS mRNA | 5q34 | |
| Tretinoin | Approved Investigational Nutraceutical | RASEF | 158158 |
upregulated | Tretinoin results in increased expression of RASEF mRNA | 9q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | RASGRP1 | 10125 |
downregulated | Tretinoin results in decreased expression of RASGRP1 mRNA | 15q14 | |
| Tretinoin | Approved Investigational Nutraceutical | RASGRP2 | 10235 |
upregulated | Tretinoin results in increased expression of RASGRP2 mRNA | 11q13.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RASL10A | 10633 |
upregulated | Tretinoin results in increased expression of RASL10A mRNA | 22q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RASL10B | 91608 |
upregulated | Tretinoin results in increased expression of RASL10B mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | RASL11A | 387496 |
upregulated | Tretinoin results in increased expression of RASL11A mRNA | 13q12.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RASL11B | 65997 |
downregulated | Tretinoin results in decreased expression of RASL11B mRNA | 4q12 | |
| Tretinoin | Approved Investigational Nutraceutical | RASSF2 | 9770 |
downregulated | Tretinoin results in decreased expression of RASSF2 mRNA | 20p13 | |
| Tretinoin | Approved Investigational Nutraceutical | RASSF2 | 9770 |
upregulated | Tretinoin results in increased expression of RASSF2 mRNA | 20p13 | |
| Tretinoin | Approved Investigational Nutraceutical | RASSF3 | 283349 |
upregulated | Tretinoin results in increased expression of RASSF3 mRNA | 12q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RASSF4 | 83937 |
upregulated | Tretinoin results in increased expression of RASSF4 mRNA | 10q11.21 | |
| Tretinoin | Approved Investigational Nutraceutical | RASSF5 | 83593 |
upregulated | Tretinoin results in increased expression of RASSF5 mRNA | 1q32.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RAX | 30062 |
downregulated | Tretinoin results in decreased expression of RAX mRNA | 18q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | RAX | 30062 |
upregulated | Tretinoin results in increased expression of RAX mRNA | 18q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | RB1 | 5925 |
upregulated | Tretinoin results in increased expression of RB1 mRNA | 13q14.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RBBP4 | 5928 |
downregulated | Tretinoin results in decreased expression of RBBP4 mRNA | 1p35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RBBP4 | 5928 |
upregulated | Tretinoin results in increased expression of RBBP4 mRNA | 1p35.1 | |
| Tretinoin | Approved Investigational Nutraceutical | RBBP8 | 5932 |
downregulated | Tretinoin results in decreased expression of RBBP8 mRNA | 18q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | RBFOX1 | 54715 |
downregulated | Tretinoin results in decreased expression of RBFOX1 mRNA | 16p13.3 | |